menu search

CASI / CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. Read More
Posted: Oct 6 2021, 10:30
Author Name: Zacks Investment Research
Views: 102072

CASI News  

Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China

By Market Watch
January 6, 2023

Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China

Shares of Casi Pharmaceuticals Inc. CASI, +3.63% were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical more_horizontal

CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022

By PRNewsWire
August 5, 2022

CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022

ROCKVILLE, Md. and BEIJING , Aug. 5, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on devel more_horizontal

CASI Pharmaceuticals stock falls after reverse split takes effect

By Market Watch
June 2, 2022

CASI Pharmaceuticals stock falls after reverse split takes effect

Shares of CASI Pharmaceuticals Inc. CASI, +18.01% are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. W more_horizontal

CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 12, 2022

CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript

CASI Pharmaceuticals, Inc. (NASDAQ:CASI ) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Wei-Wu He - Chairman and Chief more_horizontal

CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 12, 2022

CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the nu more_horizontal

CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 28, 2022

CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript

CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript more_horizontal

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

By Zacks Investment Research
October 6, 2021

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

By Zacks Investment Research
October 6, 2021

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal


Search within

Pages Search Results: